Stachybotrys chartarum

From WikiMD's WELLNESSPEDIA

2009-05-09_Stachybotrys_chartarum_(Ehrenb.)_S._Hughes_43158.jpg

Stachybotrys chartarum

Stachybotrys chartarum is a fungus that belongs to the division Ascomycota. It is commonly known as "black mold" or "toxic black mold" due to its dark green or black appearance and its potential to produce mycotoxins. This species is often found in water-damaged buildings and can pose significant health risks to humans.

Description[edit]

Stachybotrys chartarum is a saprophytic fungus that thrives on materials with high cellulose content, such as drywall, wood, and paper. It requires constant moisture to grow, making it prevalent in areas with water damage or high humidity.

Health Effects[edit]

Exposure to Stachybotrys chartarum can lead to a variety of health issues, particularly in individuals with respiratory conditions, allergies, or weakened immune systems. Symptoms of exposure may include coughing, sneezing, eye irritation, skin rashes, and in severe cases, pulmonary hemorrhage in infants. The mycotoxins produced by this mold, such as trichothecenes, are believed to be responsible for these adverse health effects.

Detection and Remediation[edit]

Detecting Stachybotrys chartarum typically involves visual inspection and sampling of the affected areas. Air sampling and surface sampling are common methods used to identify the presence of this mold. Remediation involves removing the contaminated materials, addressing the source of moisture, and thoroughly cleaning the affected areas to prevent regrowth.

Prevention[edit]

Preventing the growth of Stachybotrys chartarum involves controlling indoor humidity levels, promptly repairing water leaks, and ensuring proper ventilation in areas prone to moisture accumulation. Regular maintenance and inspection of buildings can help mitigate the risk of mold growth.

See Also[edit]

References[edit]


External Links[edit]

This article is a stub related to fungus. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.